The same is true for patients receiving GLP-1 medications
These advances are critical in translating theranostics from preclinical concept to routine clinical workflow
Wegovy (pronounced wee-GOH-vee) is a synthesized version of a gut hormone that curbs appetite
Some users report experiencing: Changes in appetite and cravings Altered eating patterns Weight changes But its worth noting this depends on other factors, too
These alterations motivate the intestine to reduce mucus manufacture (Vaziri et al., 2012), destructive the intestinal epithelium (Hobby et al., 2019), disturbing the integrity of the intestinal barrier (Plata et al., 2019), changing intestinal permeability (Meijers et al., 2018), and permitting the microflora to be transported to the systemic circulation through the blood to act on the kidneys (Shi et al., 2014)